Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 31;21(7):2413.
doi: 10.3390/ijms21072413.

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy

Naranjan S Dhalla  1   2 , Anureet K Shah  3 , Paramjit S Tappia  4
Affiliations
Review

Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy

Naranjan S Dhalla et al. Int J Mol Sci. .

Abstract

Although the presence of cardiac dysfunction and cardiomyopathy in chronic diabetes has been recognized, the pathophysiology of diabetes-induced metabolic and subcellular changes as well as the therapeutic approaches for the prevention of diabetic cardiomyopathy are not fully understood. Cardiac dysfunction in chronic diabetes has been shown to be associated with Ca2+-handling abnormalities, increase in the availability of intracellular free Ca2+ and impaired sensitivity of myofibrils to Ca2+. Metabolic derangements, including depressed high-energy phosphate stores due to insulin deficiency or insulin resistance, as well as hormone imbalance and ultrastructural alterations, are also known to occur in the diabetic heart. It is pointed out that the activation of the sympathetic nervous system and renin-angiotensin system generates oxidative stress, which produces defects in subcellular organelles including sarcolemma, sarcoplasmic reticulum and myofibrils. Such subcellular remodeling plays a critical role in the pathogenesis of diabetic cardiomyopathy. In fact, blockade of the effects of neurohormonal systems has been observed to attenuate oxidative stress and occurrence of subcellular remodeling as well as metabolic abnormalities in the diabetic heart. This review is intended to describe some of the subcellular and metabolic changes that result in cardiac dysfunction in chronic diabetes. In addition, the therapeutic values of some pharmacological, metabolic and antioxidant interventions will be discussed. It is proposed that a combination therapy employing some metabolic agents or antioxidants with insulin may constitute an efficacious approach for the prevention of diabetic cardiomyopathy.

Keywords: Ca2+-handling abnormalities; cardiac metabolism; diabetic cardiomyopathy; oxidative stress; renin-angiotensin system; subcellular remodeling; sympathetic nervous system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Role of oxidative stress in the pathogenesis of diabetic cardiomyopathy.
Figure 2
Figure 2
Role of oxidative stress in subcellular remodeling and Ca2+-handling abnormalities in the diabetic heart.
Figure 3
Figure 3
Interventions that may attenuate subcellular remodeling and improve cardiac performance in chronic diabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Regan T.J., Ahmed S., Haider B., Moschos C., Weisse A. Diabetic cardiomyopathy: Experimental and clinical observations. N. Engl. J. Med. 1994;91:776–778. - PubMed
    1. Regan T.J. Congestive heart failure in the diabetic. Ann. Rev. Med. 1983;34:161–168. doi: 10.1146/annurev.me.34.020183.001113. - DOI - PubMed
    1. Dhalla N.S., Pierce G.N., Innes I.R., Beamish R.E. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can. J. Cardiol. 1985;1:263–281. - PubMed
    1. Borghetti G., von Lewinski D., Eaton D.M., Sourij H., Houser S.R., Wallner M. Diabetic cardiomyopathy: Current and future therapies, beyond glycemic control. Front. Physiol. 2018;9:1514. doi: 10.3389/fphys.2018.01514. - DOI - PMC - PubMed
    1. Kenny H.C., Abel E.D. Heart failure in type 2 diabetes mellitus. Circ. Res. 2019;124:121–141. doi: 10.1161/CIRCRESAHA.118.311371. - DOI - PMC - PubMed